BCG-medac
BCG-medac is an originator product from Labatec Pharma SA and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 158.15 to CHF 158.15 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Labatec Pharma SA
- ATC code
- L03AX03
- IT group
- 07.16.10 Cytostatica
- Active substances
- Bacillus Calmette Guerin (BCG, RIVM),
- Preparation type
- Originator product
- On the SL since
- 01/09/2026
- Last price change
- 01/09/2026
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Trockensub + Lsg-mittel, 2*10E8 - 3*10E9 CFU | 1 Durchstf + 1 Instillationsbtl mit Lsg-mittel + Katheter + Gleitgel | CHF 130.32 | CHF 158.15 | 01/09/2026 | A | 7680699540013 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
BCG-medac wird vergütet für die Behandlung nicht-invasiver urothelialer Harnblasenkarzinome:
- Kurative Behandlung eines Carcinoma in situ
- Prophylaktische Behandlung zur Vermeidung eines erneuten Auftretens von:
- Urothelialen Karzinomen beschränkt auf die Schleimhaut
- Ta G1-G2 bei einem multifokalen Tumor und/oder Tumorrezidiv
- Ta G3
- Urothelialen Karzinomen in der Lamina propria, aber nicht im Muskelgewebe der Blase (T1)
- Carcinoma in situ
- Urothelialen Karzinomen beschränkt auf die Schleimhaut
More preparations in this group
FAQ
Is BCG-medac covered by Swiss health insurance?
Yes, but only under conditions. BCG-medac is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does BCG-medac cost in Switzerland?
The public price is the maximum price set by the FOPH and for BCG-medac ranges from CHF 158.15 to CHF 158.15 per pack. The ex-factory price ranges from CHF 130.32 to CHF 130.32. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages